A detailed history of Victory Capital Management Inc transactions in Maxcyte, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 12,289 shares of MXCT stock, worth $42,274. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,289
Previous 11,880 3.44%
Holding current value
$42,274
Previous $46,000 2.17%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$3.68 - $5.06 $1,505 - $2,069
409 Added 3.44%
12,289 $47,000
Q2 2024

Aug 05, 2024

SELL
$3.63 - $5.0 $417 - $575
-115 Reduced 0.96%
11,880 $46,000
Q1 2024

May 03, 2024

SELL
$3.94 - $5.38 $1,264 - $1,726
-321 Reduced 2.61%
11,995 $50,000
Q4 2023

Feb 05, 2024

BUY
$2.6 - $5.24 $5,995 - $12,083
2,306 Added 23.04%
12,316 $57,000
Q3 2023

Nov 06, 2023

BUY
$3.02 - $5.1 $30,230 - $51,051
10,010 New
10,010 $31,000

Others Institutions Holding MXCT

About MAXCYTE, INC.


  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $350M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.